Latest / Research To Practice | Oncology Videos
Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Erika Hamilton: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Featuring an interview with Dr Erika Hamilton, including the following topics:
Monitoring, mitigating and managing adverse events with antibody-drug conjugates (ADCs) for breast cancer (0:00)
Heist RS et al. Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan. Cancer Treat Rev 2024;125:102720. Abstract
Management protocols for adverse events associated with sacituzumab govitecan (7:49)
García JMP et al. Prevention of sacituzumab govitecan (SG)-related neutropenia and diarrhea in patients with triple-negative or…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.